56 related articles for article (PubMed ID: 3720215)
21. A quantitative analysis of dependence of platelet aggregation inhibition and hypotensive activities of dihydropyridazinone derivatives on molecular size.
Gupta SP; Shewade DG; Garg C; Handa A; Prabhakar YS
Indian J Biochem Biophys; 1985 Apr; 22(2):122-5. PubMed ID: 4065928
[No Abstract] [Full Text] [Related]
22. 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A agonists that demonstrate oral activity as satiety agents.
Henke BR; Willson TM; Sugg EE; Croom DK; Dougherty RW; Queen KL; Birkemo LS; Ervin GN; Grizzle MK; Johnson MF; James MK
J Med Chem; 1996 Jul; 39(14):2655-8. PubMed ID: 8709093
[No Abstract] [Full Text] [Related]
23. Antiplatelets activity of some xanthone derivatives.
Rajtar G; Zółkowska D; Kleinrok Z; Marona H
Acta Pol Pharm; 1999; 56(4):319-24. PubMed ID: 10635366
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and anti-platelet evaluation of 2-benzoylaminobenzoate analogs.
Hsieh PW; Chiang SZ; Wu CC; Lo YC; Shih YT; Wu YC
Bioorg Med Chem; 2008 May; 16(10):5803-14. PubMed ID: 18407506
[TBL] [Abstract][Full Text] [Related]
25. [Inhibitors of thrombocyte aggregation].
Lakin KM; Makarov VA; Novikova NV; Tret'iak VM
Farmakol Toksikol; 1983; 46(3):113-26. PubMed ID: 6134634
[No Abstract] [Full Text] [Related]
26. Structure-activity relationship in the effect of 1,4-benzodiazepines on morphine, aminopyrine and oestrone metabolism.
Vega P; Carrasco M; Sanchez E; del Villar E
Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):179-98. PubMed ID: 6429801
[TBL] [Abstract][Full Text] [Related]
27. Reevaluation of the role of the polar groups of collagen in the platelet-collagen interaction.
Chesney CM; Pifer DD; Crofford LJ; Huch KM
Am J Pathol; 1983 Aug; 112(2):200-6. PubMed ID: 6881287
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of N1-substituted benzamidines. Effects on blood coagulation, platelet aggregation and antiarrhythmic activity.
Ferroni R; Simoni D; Manfredini S; Guarneri M; Orlandini P; Barbieri M; Franzè GP; Mugelli A
Arzneimittelforschung; 1995 Jun; 45(6):665-9. PubMed ID: 7646567
[TBL] [Abstract][Full Text] [Related]
29. Analysis of anti-PDE3 activity of 2-morpholinochromone derivatives reveals multiple mechanisms of anti-platelet activity.
Abbott BM; Thompson PE
Bioorg Med Chem Lett; 2006 Feb; 16(4):969-73. PubMed ID: 16290931
[TBL] [Abstract][Full Text] [Related]
30. [The action of the alkanol ammonium salts of aroxyacetic acids on the thrombocyte aggregation process].
Kazimirovskaia VB; Semenova NV; Moskvitina LT; Nepsha VD; Novikova NV; Voronkov MG
Eksp Klin Farmakol; 1995; 58(3):37-40. PubMed ID: 7663294
[TBL] [Abstract][Full Text] [Related]
31. Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation.
Gueguen G; Gaigé B; Grévy JM; Rogalle P; Bellan J; Wilson M; Klaébé A; Pont F; Simon MF; Chap H
Biochemistry; 1999 Jun; 38(26):8440-50. PubMed ID: 10387090
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and receptor binding studies of 2-functionalized 1,4-benzodiazepine derivatives as potential metaclazepam-like antianxiety agents.
Anzini M; Cappelli A; Vomero S; Cagnotto A; Skorupska M
Farmaco; 1993 Jul; 48(7):897-905. PubMed ID: 8104405
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacologic effects of tofizopam (Grandaxin)].
Petócz L
Acta Pharm Hung; 1993 Mar; 63(2):79-82. PubMed ID: 8100112
[TBL] [Abstract][Full Text] [Related]
34. [Quantitative relationship between the structure and inhibition of thrombocyte aggregation in the arylaliphatic acid group].
Kuchar M; Rejholec V; Brůnová B; Nĕmecek O; Cepelák V
Cesk Farm; 1983 May; 32(3-4):116-21. PubMed ID: 6872011
[No Abstract] [Full Text] [Related]
35. Unique pharmacologic profile of triazolobenzodiazepines.
Lesar TS
Clin Pharm; 1986 Jun; 5(6):468-9. PubMed ID: 3720215
[No Abstract] [Full Text] [Related]
36. Benzodiazepines.
Killam EK; Suria A
Adv Neurol; 1980; 27():597-615. PubMed ID: 6990714
[No Abstract] [Full Text] [Related]
37. Pharmacologic effects of the triazolo group.
Taniguchi G
Clin Pharm; 1985; 4(3):258, 266. PubMed ID: 4006393
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
